Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Involvement of ER Stress in Dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 Missense Mutations Shown by iPSC-Derived Oligodendrocytes.
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE).
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Helicobacter pylori Infection in Neuromyelitis Optica and Multiple Sclerosis.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
Advancing therapeutic options in multiple sclerosis with neuroprotective properties.
[Quality of life of patients receiving long-term treatment with first-line disease-modifying drugs: results of a Russian multicenter study using MusiQoL.]
Optical Coherence Tomography for the Radiologist.
Peripheral tolerance and autoimmunity: lessons from in vivo imaging.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
The role of the immune system in the generation of neuropathic pain.
Comparison of Standard 1.5 T vs. 3 T Optimized Protocols in Patients Treated with Glatiramer Acetate. A Serial MRI Pilot Study.
Anthraquinone derivative O,O'-bis-(3'-iodopropyl)-1,4-dihidroxyanthraquinone modulates immune response and improves experimental autoimmune encephalomyelitis.
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial.
Introducing demographic corrections for the 10/36 Spatial Recall Test.
Control of experimental spasticity by targeting the degradation of endocannabinoids using selective fatty acid amide hydrolase inhibitors.
Sub-millimeter imaging of brain-free water for rapid volume assessment in atrophic brains.
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Prevalence of Radiologically Isolated Syndrome and White Matter Signal Abnormalities in Healthy Relatives of Multiple Sclerosis Patients.
Is anemia a probable cause of fatigue in patients with multiple sclerosis?
PML in MS Patients Making Natalizumab-to-Fingolimod Switch
Developing a therapeutic plan for treating MS: evidence for new treatments.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Cognitive reserve and patient-reported outcomes in multiple sclerosis.

Pages